EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Prognostic Value of the CD8+PD-1+/CD4+PD-1+ (PERLS) Ratio for Leukemic Transformation in MDS

Panagiotis Panagiotidis, Emmanuel Karavanis, Konstantinos Neanidis, Eleftherios Panteris iD, Maria Moysidou iD

Hematology Reports · 15.04.2026 · 18 (2) · 29

DOI: 10.3390/hematolrep18020029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology Reports, online erschienen am 15.04.2026. Verfasst von Panagiotis Panagiotidis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oncology/Hematology Clinic, 424 General Military Hospital (424 GMHT), 56429 Thessaloniki, Greece. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Myelodysplastic syndromes (MDS) are associated with a significant risk of progression to acute myeloid leukemia (AML), affecting approximately 30% of patients. In high-risk MDS, leukemic transformation may occur within a short time frame, highlighting the need for early and reliable biomarkers of disease progression. Increasing evidence suggests that immune dysregulation and cytotoxic T-cell dysfunction contribute to disease evolution. This study aimed to evaluate PD-1 and CD57 expressions on CD8+ T cells and to investigate the CD8+PD-1+/CD4+PD-1+ ratio (PERLS) as a potential immunological marker predictive of leukemic transformation.

Methods

Thirty-one patients with MDS were prospectively followed over a 12-month period. At baseline, patients underwent routine clinical and laboratory evaluation, including multiparameter flow cytometric assessment of bone marrow blasts. An extended immunophenotypic analysis of bone marrow samples was performed at study entry to assess PD-1 and CD57 expression on CD8+ T cells. Cytogenetic and molecular analyses were conducted when clinical findings suggested disease progression. Patients who developed signs of progression were re-evaluated approximately one month later, during the progression phase, to assess dynamic immunological changes.

Results

Of the thirty-one patients included, eighteen progressed to AML, whereas thirteen remained clinically stable. Patients who progressed demonstrated a significant increase in PD-1 and CD57 expression on CD8+ T cells compared with stable patients. Moreover, a markedly higher CD8+PD-1+/CD4+PD-1+ (PERLS) ratio was observed in patients who subsequently developed AML, particularly during the progression phase.

Conclusions

Dynamic immunophenotypic monitoring reveals that increased PD-1 on CD8+ T cells and an elevated PERLS ratio are associated with imminent leukemic transformation in MDS. These findings support the incorporation of immune-based biomarkers, particularly the CD8+PD-1+/CD4+PD-1+ ratio, into routine risk assessment to enable earlier identification of disease progression and timely therapeutic intervention.

Schlagwörter

Stichwörter der Autor:innen

CD57+CD8+ T cellsCD8+PD-1+/CD4+PD-1+ (PERLS)PD-1acute myeloid leukemiamyelodysplastic syndromes

Autor:innen und Institutionen

  • Oncology/Hematology Clinic, 424 General Military Hospital (424 GMHT), 56429 Thessaloniki, Greece.
  • Biomedical Sciences Unit, Faculty of Health Sciences, Metropolitan College, Campus of Thessaloniki, 54626 Thessaloniki, Greece.
  • Neonatology/Neonatal Intensive Care Unit (NICU), University General Hospital of Heraklion, University of Crete, 71003 Heraklion, Greece.

ORCID-Profile: Eleftherios Panteris, Maria Moysidou

Zitieren

APA

Panagiotidis, P., Karavanis, E., Neanidis, K., Panteris, E., & Moysidou, M. (2026). The Prognostic Value of the CD8+PD-1+/CD4+PD-1+ (PERLS) Ratio for Leukemic Transformation in MDS. Hematology Reports, 18(2), 29. https://doi.org/10.3390/hematolrep18020029

Vancouver

Panagiotidis P, Karavanis E, Neanidis K, Panteris E, Moysidou M. The Prognostic Value of the CD8+PD-1+/CD4+PD-1+ (PERLS) Ratio for Leukemic Transformation in MDS. Hematology Reports. 2026;18(2):29. doi:10.3390/hematolrep18020029

BibTeX
@article{Panagiotidis2026,
  author = {Panagiotidis, Panagiotis and Karavanis, Emmanuel and Neanidis, Konstantinos and Panteris, Eleftherios and Moysidou, Maria},
  title = {The Prognostic Value of the CD8+PD-1+/CD4+PD-1+ (PERLS) Ratio for Leukemic Transformation in MDS},
  journal = {Hematology Reports},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {29},
  doi = {10.3390/hematolrep18020029}
}
Kostenlos starten →